Summary
The treatment of children with idiopathic nephrotic syndrome who have multiple relapses or who are steroid-resistant is a difficult issue. Alkylating agents are often proposed but they have several side effects, including gonadal toxicity, which limit their use. Treatment with levamisole may be efficient in steroid-dependent patients, allowing prednisone to be tapered or stopped in approximately 50% of cases. Cyclosporine has proved to be effective in 85% of steroid-dependent patients, but most patients relapse when cyclosporine is tapered or withdrawn. Thus, in these patients, cyclosporine may be required for long periods of time. Conversely, cyclosporine alone is less effective in steroid-resistant patients, as only 28% of these patients respond to the treatment. Cyclosporine in association with prednisone may be a better alternative as, in our experience, 14 out of 31 patients went into remission with such treatment. It should be stressed that response to cyclosporine is better correlated with initial steroid responsiveness than with histological category. Eighteen out of 43 patients with serial renal biopsies developed significant tubulo interstitial lesions which could be attributable to cyclosporine nephrotoxicity. The risk of developing chronic nephrotoxicity appears to be higher in steroid-resistant patients. Cyclosporine nephrotoxicity is not related to the duration of treatment and may develop in patients with normal renal function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Habib R, Churg J (1984) Minimal change disease, mesangial proliferation glomerulo-nephritis and focal sclerosis: individual entities or a spectrum. In: RR Robinson (ed) Nephrology. Springer, New York, pp 634–644
Niaudet P, Habib R, Gagnadoux MF, Tête MJ, Broyer M (1988) Treatment of severe childhood nephrosis. In: Grunfeld JP, Bach JF, Crosnier J, Funk-Brentano JL, Maxwell MH (eds) Advances in nephrology. Year Book Medical, pp 151–172
Tanphaichitr P, Tanphaichitr D, Sureesatanan J (1980) Treatment of nephrotic syndrome with levamisole. J Pediatr 96: 490–493
Mehta K, Ali U (1987) New approach to relapsing nephrotic syndrome. Pediatr Nephrol 1: C46
Mongeau JG, Robitaille PO, Roy F (1988) Clinical efficacy of levamisole in the treatment of primary nephrosis in children. Pediatr Nephrol 2: 398–401
Meyrier A, Simon P, Perret G, Condamin-Meyrier MC (1986) Remission of idiopathic nephrotic syndrome after treatment with cyclosporine A. Br Med J [Clin Res] 292: 789–793
Hoyer PF, Krull F, Brodehl J (1986) Cyclosporine in frequently relapsing minimal change nephrotic syndrome. Lancet II: 385
Capodicasa G, De Santo NG, Nuzzi F, Giordano C (1986) Cyclosporine A in nephrotic syndrome of childhood. A 14 month experience. Int J Pediatr Nephrol 7: 69–72
Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR (1988) Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 33: 729–734
Brandis M, Burghard R, Leititis J, Zimmerhackl B, Hildebrandt F, Helmcher U (1988) Cyclosporine A for treatment of nephrotic syndrome. Transplant Proc 20 (Suppl 4): 275–279
Waldo FB, Kohaut EC (1987) Therapy of focal segmental glomerulosclerosis with cyclosporine A. Pediatr Nephrol 1: 180–182
Brodehl J, Hoyer PF (1989) Cyclosporin in idiopathic nephrotic syndrome of children. Am J Nephrol 9 (Suppl 1): 61–64
Niaudet P, the French Society of Pediatric Nephrology. (to be published) Steroid resistant idiopathic nephrotic syndrome and cyclosporine. Nephron
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Japan
About this chapter
Cite this chapter
Niaudet, P., Broyer, M., Habib, R. (1991). New Therapies for the Treatment of Idiopathic Nephrotic Syndrome. In: Hatano, M. (eds) Nephrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-35158-1_151
Download citation
DOI: https://doi.org/10.1007/978-3-662-35158-1_151
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70074-6
Online ISBN: 978-3-662-35158-1
eBook Packages: Springer Book Archive